(Q33255028)

24 July 2017

title

Two approaches to drug discovery in SOD1-mediated ALS. (English)

1 reference

amyotrophic lateral sclerosis

24 July 2017

main subject

1 reference

1 reference

9

Robert H Brown

1 reference

24 July 2017

Wendy J Broom

1

1 reference

24 July 2017

Kristen E Auwarter

2

1 reference

24 July 2017

Jake Ni

3

1 reference

24 July 2017

Deborah E Russel

4

1 reference

24 July 2017

Li-An Yeh

5

1 reference

24 July 2017

Michele M Maxwell

6

1 reference

24 July 2017

Marcie Glicksman

7

1 reference

24 July 2017

Aleksey G Kazantsev

8

1 reference

24 July 2017

publication date

23 August 2006

1 reference

Journal of Biomolecular Screening

24 July 2017

published in

1 reference

24 July 2017

volume

11

1 reference

24 July 2017

issue

7

1 reference

24 July 2017

page(s)

729-735

1 reference

Mutant dynactin in motor neuron disease.

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

CuZn superoxide dismutase (SOD-1):tetanus toxin fragment C hybrid protein for targeted delivery of SOD-1 to neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057106290937

21 January 2018

Identifiers

DOI

10.1177/1087057106290937

1 reference

24 July 2017

1 reference